SPOTLIGHT -
Dr. Hormigo on the Current Treatment Landscape of Glioblastoma
Adilia Hormigo, MD, PhD, discusses the current treatment landscape of glioblastoma.
Read More
Dr. Hormigo on the Impact of COVID-19 on High Density Areas
Adilia Hormigo, MD, PhD, discusses the impact of the coronavirus disease 2019 (COVID-19) on high density areas.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
